| Date | Form | Description | Docs | XBRL | Pages |
| 07/02/20 | DEF 14A | Definitive proxy statements |
|
46 | |
| 07/02/20 | 8-K | Current report filing |
|
6 | |
| 06/22/20 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
46 | |
| 06/17/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/16/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/12/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/09/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
60 |
| 05/04/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/20/20 | 8-K | Current report filing |
|
3 | |
| 03/17/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences' CAR-T Cancer Therapy Receives Intention to Grant Notice from the European Patent Office
Read More...Anixa and OntoChem Announce Completion of Initial Screening Program and Identification of Additional Covid-19 Compounds
Read More...Anixa Announces Strategic Program Realignment Focused on Advancement of its Therapeutic and Vaccine Pipeline
Read More...